These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8146892)

  • 1. Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O.
    Lenny LL; Hurst R; Goldstein J; Galbraith RA
    Transfusion; 1994 Mar; 34(3):209-14. PubMed ID: 8146892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O: report on the end of phase 1 trials.
    Lenny LL; Hurst R; Zhu A; Goldstein J; Galbraith RA
    Transfusion; 1995; 35(11):899-902. PubMed ID: 8604485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-unit transfusions of RBC enzymatically converted from group B to group O to A and O normal volunteers.
    Lenny LL; Hurst R; Goldstein J; Benjamin LJ; Jones RL
    Blood; 1991 Mar; 77(6):1383-8. PubMed ID: 1848117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O.
    Kruskall MS; AuBuchon JP; Anthony KY; Herschel L; Pickard C; Biehl R; Horowitz M; Brambilla DJ; Popovsky MA
    Transfusion; 2000 Nov; 40(11):1290-8. PubMed ID: 11099655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Jka, -C, and -E in a single patient, initially demonstrable only by the manual hexadimethrine bromide (Polybrene) test, with incompatibilities confirmed by 51Cr-labeled red cell studies.
    Maynard BA; Smith DS; Farrar RP; Kraetsch RE; Chaplin H
    Transfusion; 1988; 28(4):302-6. PubMed ID: 3133842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood transfusion in the para-Bombay phenotype.
    Lin-Chu M; Broadberry RE
    Br J Haematol; 1990 Aug; 75(4):568-72. PubMed ID: 2207009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of transfusable human universal red blood cell with recombinant alpha-galactosidase].
    Gong F; Lü QS; You Y; Gao HW; Bao GQ; Gao X; Li SB; Li LL; Wang YL; Tian SG; Zhang ZX; Zhang P; Zhang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):313-6. PubMed ID: 15854299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case for stocking O D+ red blood cells in emergency room trauma bays.
    Meyer E; Uhl L
    Transfusion; 2015 Apr; 55(4):791-5. PubMed ID: 25444310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-A antibody transfused with non-group-specific platelets. Serological abnormalities.
    Thomas L; Tuscany FL; Wilner GD
    Arch Pathol Lab Med; 1981 Jan; 105(1):52-3. PubMed ID: 6893913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designer red cells.
    Wilson RB; Spitalnik SL
    Transfusion; 1994 Mar; 34(3):189-91. PubMed ID: 8146889
    [No Abstract]   [Full Text] [Related]  

  • 11. Modifying the red cell surface: towards an ABO-universal blood supply.
    Olsson ML; Clausen H
    Br J Haematol; 2008 Jan; 140(1):3-12. PubMed ID: 17970801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal red blood cells--enzymatic conversion of blood group A and B antigens.
    Olsson ML; Hill CA; de la Vega H; Liu QP; Stroud MR; Valdinocci J; Moon S; Clausen H; Kruskall MS
    Transfus Clin Biol; 2004 Feb; 11(1):33-9. PubMed ID: 14980547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of group A1B erythrocytes converted to type as group O: studies of markers of function and compatibility.
    Gao HW; Zhuo HL; Zhang X; Ji SP; Tan YX; Li SB; Jia YJ; Xu H; Wu QF; Yun ZM; Luo Q; Gong F
    Blood Transfus; 2016 Mar; 14(2):168-74. PubMed ID: 26509826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxysmal nocturnal hemoglobinuria and the transfusion of washed red cells. A myth revisited.
    Brecher ME; Taswell HF
    Transfusion; 1989 Oct; 29(8):681-5. PubMed ID: 2799892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O- product transfusion, inventory management, and utilization during shortage: the OPTIMUS study.
    Dunbar NM; Yazer MH;
    Transfusion; 2018 Jun; 58(6):1348-1355. PubMed ID: 29479703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Time of Cross-Match Incompatible Red Blood Cells in Adult Horses.
    Tomlinson JE; Taberner E; Boston RC; Owens SD; Nolen-Walston RD
    J Vet Intern Med; 2015; 29(6):1683-8. PubMed ID: 26478135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythrocyte detection with the immunoperoxidase method following 2 failed transfusions in ABO and Rhesus incompatibility--clinical course].
    Heim MU; Pachmann U; Böck M; Geschwändler E; Schleifer A; Eckstein R; Mempel W
    Beitr Infusionsther; 1988; 21():255-8. PubMed ID: 2462987
    [No Abstract]   [Full Text] [Related]  

  • 19. Hb content-based transfusion policy successfully reduces the number of RBC units transfused.
    Arslan O; Toprak S; Arat M; Kayalak Y
    Transfusion; 2004 Apr; 44(4):485-8. PubMed ID: 15043562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient ABO blood type is a major predictor of a positive DAT following a transfusion reaction.
    Schnieders E; Leon J; Chapman JM; Knudson CM
    Transfusion; 2022 Sep; 62(9):1715-1719. PubMed ID: 35836408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.